Search results for “ANGPTL3” companies
Free sign up to view the full data
Key Players
Order by:
Innovation Intensity
With the analysis among 410 patents, we discovered top 32 key players by total patent application. Regeneron Pharmaceuticals, Inc., Ionis Pharmaceuticals, Inc., Alnylam Pharmaceuticals, Inc. are dominant in this area. They take 57.07% of the total patent filing.
Regeneron Pharmaceuticals, Inc.
New York, United States
Patent: 110
Ionis Pharmaceuticals, Inc.
California, United States
Patent: 63
Alnylam Pharmaceuticals, Inc.
Massachusetts, United States
Patent: 61
Eli Lilly & Co.
Indiana, United States
Patent: 29
Arrowhead Pharmaceuticals, Inc.
California, United States
Patent: 23
Lexicon Pharmaceuticals, Inc.
Texas, United States
Patent: 18
Jiangsu Hengrui Pharmaceuticals Co., Ltd.
Jiangsu Sheng, China
Patent: 15
Shanghai Hengrui Pharmaceutical Co., Ltd.
Shanghai Shi, China
Patent: 15
Verve Therapeutics, Inc.
Massachusetts, United States
Patent: 12
Genentech, Inc.
California, United States
Patent: 10
Startups & Unicorns
Order by:
Innovation Intensity
No data, please try another search term
Fast-Growing
Order by:
Innovation in recent 5 years
With the analysis among related 236 patents applied in the last 5 years. We discover 32 most active companies in this area. The fast-growing Regeneron Pharmaceuticals, Inc., Eli Lilly & Co., Alnylam Pharmaceuticals, Inc. take 44.07% of patent filing during this period.
Regeneron Pharmaceuticals, Inc.
New York, United States
Patent: 48
Eli Lilly & Co.
Indiana, United States
Patent: 30
Alnylam Pharmaceuticals, Inc.
Massachusetts, United States
Patent: 26
Arrowhead Pharmaceuticals, Inc.
California, United States
Patent: 23
Ionis Pharmaceuticals, Inc.
California, United States
Patent: 16
Shanghai Hengrui Pharmaceutical Co., Ltd.
Shanghai Shi, China
Patent: 15
Jiangsu Hengrui Pharmaceuticals Co., Ltd.
Jiangsu Sheng, China
Patent: 15
Verve Therapeutics, Inc.
Massachusetts, United States
Patent: 12
Dicerna Pharmaceuticals, Inc.
Massachusetts, United States
Patent: 10
Suzhou Ruibo Biological Technology Co Ltd
Jiangsu Sheng, China
Patent: 8
New Entrants
Order by:
Innovation in recent 5 years
With the analysis among related 236 patents in last 5 years, we discover 27 new entrants. Eli Lilly & Co., Arrowhead Pharmaceuticals, Inc., Shanghai Hengrui Pharmaceutical Co., Ltd. are the most active new entrants in this area.
Eli Lilly & Co.
Indiana, United States
Patent: 30
Arrowhead Pharmaceuticals, Inc.
California, United States
Patent: 23
Shanghai Hengrui Pharmaceutical Co., Ltd.
Shanghai Shi, China
Patent: 15
Jiangsu Hengrui Pharmaceuticals Co., Ltd.
Jiangsu Sheng, China
Patent: 15
Verve Therapeutics, Inc.
Massachusetts, United States
Patent: 12
Dicerna Pharmaceuticals, Inc.
Massachusetts, United States
Patent: 10
Suzhou Ruibo Biological Technology Co Ltd
Jiangsu Sheng, China
Patent: 8
CRISPR Therapeutics AG
Massachusetts, United States
Patent: 6
Zydus Lifesciences Ltd.
Gujarat, India
Patent: 4
uniQure IP BV
Netherlands
Patent: 3
Research Institutions
Order by:
Innovation Intensity
With the analysis among 11 patents, we discovered top 5 universities and scientific research institutions by total patent application. The Scripps Research Institute, Zhejiang University, Fudan University are dominant in this area. They take 63.64% of the total patent filing.
The Scripps Research Institute
California, United States
Patent: 3
Zhejiang University
Zhejiang Sheng, China
Patent: 2
Fudan University
Shanghai Shi, China
Patent: 1
China Pharmaceutical University
Jiangsu Sheng, China
Patent: 1
Kumamoto University
Kumamoto-ken, Japan
Patent: 1
Keywords Quick Entry
Popular
Physics
Chemistry
Engineering
Materials science
Computer science
Biology
Medicine
MetalElectrodeVoltageSemiconductorPolymerElectricityCoatingFiberDisplay deviceRaw materialElectric motorUltimate tensile strengthNozzleCarbonBuilding constructionAlkylService lifeElectronOxideOxygenSolventControl unitFlangeControl systemDrugLight sourcePistonDiseaseElectric powerHigh pressure
View more
Page generation time: